EXCLI J EXCLI Journal 1611-2156 Leibniz Research Centre for Working Environment and Human Factors 2013-620 Doc1017 Editorial material Highlight report: Functional consequences of urinary bladder cancer risk variants Selinski Silvia * 1 Leibniz Research Centre for Working Environment and Human Factors, Dortmund/Germany *To whom correspondence should be addressed: Silvia Selinski, Leibniz Research Centre for Working Environment and Human Factors, Dortmund/Germany, E-mail: Selinski@ifado.de 05 12 2013 2013 12 1017 1019 04 12 2013 05 12 2013 Copyright © 2013 Selinski 2013

This is an Open Access article distributed under the following Assignment of Rights http://www.excli.de/documents/assignment_of_rights.pdf. You are free to copy, distribute and transmit the work, provided the original author and source are credited.

 This article is available from http://www.excli.de/vol12/Selinski_05122013_proof.pdf 

About 180,000 new cases of urinary bladder cancer are diagnosed each year in the European Union. The most relevant risk factors are occupational exposure to aromatic amines and cigarette smoking (Golka et al., 2012[8]; Ovsiannikov et al., 2012[17]; Selinski et al., 2013[23]; Kempkes et al., 1996[12]). Recently, genome-wide association studies have successfully identified several urinary bladder cancer susceptibility loci (review: Dudek et al., 2013[4]; Golka et al., 2011[10]; Selinski, 2012[22]; Bolt, 2013[1][2]). Currently confirmed genetic variants include rs9642880 (MYC, Kiemeney et al., 2008[14]; Golka et al., 2009[9]), rs710521 (TP63, Kiemeney et al., 2008[14]; Lehmann et al., 2010[15]), rs401681 and rs2736098 (CLPTM1L, TERT, Rafnar et al., 2009[18]), rs2294008 and rs2978974 (PSCA, Wu et al., 2009[27]; Fu et al., 2012[5]), rs798766 (TACC3, FGFR3, Kiemeney et al., 2010[13]), rs11892031 (UGT1A, Rothman et al., 2010[20]; Selinski et al., 2012[25]), rs17863783 (UGT1A6, Tang et al., 2012[26]), rs1495741 (NAT2, Rothman et al., 2010[20]; Garcia-Closas et al., 2011[6]; Selinski et al., 2011[24]), rs8102137 (CCNE1, Rothman et al., 2010[20]), rs1014971 (CBX6, Rothman et al., 2010[20]) and rs17674580 and rs1058396 (SLC14A1, Rafnar et al., 2011[19]). Moreover, it has been shown that several high risk alleles of single nucleotide polymorphisms can interact leading to enhanced odds ratios (Schwender et al., 2012[21]). However, relatively little is known about the functional consequences of the novel bladder cancer susceptibility SNPs. Many of them are located in non-coding regions. An example is rs9642880 on chromosome 8q24 that is approximately 30kb upstream of MYC (Kiemeney et al., 2008[14]). Similarly, rs1014971 on 22q13.1 is located 25 kb and 64kb from APOBEC3A and CBX6, respectively (Rothman et al., 2010[20]). Considering these relatively large distances between both SNPs and the closest exons it seems unlikely that an influence can be explained by linkage disequilibrium. Recently, Dudek and colleagues have addressed the open question of the functional consequences of urinary bladder susceptibility loci (Dudek et al., 2013[4]). At least two risk variants, located in PSCA and UGT1A, were confirmed to have functional consequences.

PSCA (prostate stem cell antigen) is involved in the regulation of stem cell proliferation. Rs2294008 is located in the first exon of PSCA (review: Dudek et al., 2013[4]). It changes a nucleotide in the initiation region, creates a new ATG for translation initiation leading to a PSCA protein which is nine amino acids longer (Dudek et al., 2013[4]). Rs294008 was found to be strongly associated with PSCA protein levels in urinary bladder tumors. Moreover, a second variant, rs2978974, was also identified in exon 1 of PSCA and was found to be associated with urinary bladder cancer risk (Fu et al., 2012[5]; review: Dudek et al., 2013[4]).

UDP-glucuronosyltransferase (UGT) is a phase II metabolizing enzyme involved in detoxification of numerous carcinogens (Burkhardt et al., 2012[3]; Hanioka et al., 2011[11]; Luo et al., 2012[16]; Godoy et al., 2013[7]). One bladder cancer susceptibility locus is located in intron 1 of UGT, containing rs11892031 (Rothman et al., 2010[20]; Dudek et al., 2013[4]). Follow-up studies identified the causative variant rs17863783 (Tang et al. 2012[26]). Rs17863783 does not alter the amino acid sequence of UGT1A. However, a possible explanation is that rs17863783 modifies the expression of UGT1A by influencing the exonic splicing enhancer, a DNA sequence motif essential for the identification of splice sites (Dudek et al., 2013[4]).

The current review article of Dudek et al. (2013[4]) describes in a comprehensive way the current concepts by which mechanisms the recently identified bladder cancer risk loci may contribute to carcinogenesis.

 Bolt HM Human bladder cancer risk calculation based on genome-wide analysis of genetic variants Arch Toxicol 2013 87 397 399 Bolt HM Relevance of genetic disposition versus environmental exposure for cancer risk: an old controversy revisited with novel methods EXCLI J 2013 79 196 200 Burkhardt B Jung SA Pfeiffer E Weiss C Metzler M Mouse hepatoma cell lines differing in aryl hydrocarbon receptor-mediated signaling have different activities for glucuronidation Arch Toxicol 2012 86 643 649 Dudek AM Grotenhuis AJ Vermeulen SH Kiemeney LA Verhaegh GW Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms? Int J Mol Sci 2013 14 12346 12366 Fu YP Kohaar I Rothman N Earl J Figueroa JD Ye Y Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk Proc Natl Acad Sci U S A 2012 109 4974 4979 García-Closas M Hein DW Silverman D Malats N Yeager M Jacobs K A single nucleotide polymorphism tags variation in the arylamine N-acetyltransferase 2 phenotype in populations of European background Pharmacogenet Genomics 2011 21 231 236 Godoy P Hewitt NJ Albrecht U Andersen ME Ansari N Bhattacharya S Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME Arch Toxicol 2013 87 1315 1530 Golka K Abreu-Villaca Y Anbari Attar R Angeli-Greaves M Aslam M Basaran N Bladder cancer documentation of causes: multilingual questionnaire, 'bladder cancer doc' Front Biosci (Elite Ed) 2012 4 2809 2822 Golka K Hermes M Selinski S Blaszkewicz M Bolt HM Roth G Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure Pharmacogenet Genomics 2009 19 903 906 Golka K Selinski S Lehmann ML Blaszkewicz M Marchan R Ickstadt K Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs" Arch Toxicol 2011 85 539 554 Hanioka N Oka H Nagaoka K Ikushiro S Narimatsu S Effect of UDP-glucuronosyltransferase 2B15 polymorphism on bisphenol A glucuronidation Arch Toxicol 2011 85 1373 1381 Kempkes M Golka K Reich S Reckwitz T Bolt HM Glutathione S-transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder Arch Toxicol 1996 71 123 126 Kiemeney LA Sulem P Besenbacher S Vermeulen SH Sigurdsson A Thorleifsson G A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer Nat Genet 2010 42 415 419 Kiemeney LA Thorlacius S Sulem P Geller F Aben KK Stacey SN Sequence variant on 8q24 confers susceptibility to urinary bladder cancer Nat Genet 2008 40 1307 1312 Lehmann ML Selinski S Blaszkewicz M Orlich M Ovsiannikov D Moormann O Rs710521[A] on chromosome 3q28 close to TP63 is associated with increased urinary bladder cancer risk Arch Toxicol 2010 84 967 978 Luo CF Cai B Hou N Yuan M Liu SM Ji H UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for puerarin metabolism in human liver microsomes. Arch Toxicol. 2012;86:1681-90 Arch Toxicol 2012 86 1681 1690 Ovsiannikov D Selinski S Lehmann ML Blaszkewicz M Moormann O Haenel MW Polymorphic enzymes, urinary bladder cancer risk, and structural change in the local industry J Toxicol Environ Health A 2012 75 557 565 Rafnar T Sulem P Stacey SN Geller F Gudmundsson J Sigurdsson A Sequence variants at the TERT-CLPTM1L locus associate with many cancer types Nat Genet 2009 41 221 227 Rafnar T Vermeulen SH Sulem P Thorleifsson G Aben KK Witjes JA European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene Hum Mol Genet 2011 20 4268 4281 Rothman N Garcia-Closas M Chatterjee N Malats N Wu X Figueroa JD A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci Nat Genet 2010 42 978 984 Schwender H Selinski S Blaszkewicz M Marchan R Ickstadt K Golka K Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers PLoS One 2012 7 e51880 Selinski S Genetic variants confer susceptibility to urinary bladder cancer: an updated list of confirmed polymorphisms EXCLI J 2012 11 743 747 Selinski S Blaszkewicz M Agundez JA Martinez C Garcia-Martin E Hengstler JG Clarifying haplotype ambiguity of NAT2 in multi-national cohorts Front Biosci (Schol Ed) 2013 5 672 684 Selinski S Blaszkewicz M Lehmann ML Ovsiannikov D Moormann O Guballa C Genotyping NAT2 with only two SNPs (rs1041983 and rs1801280) outperforms the tagging SNP rs1495741 and is equivalent to the conventional 7-SNP NAT2 genotype Pharmacogenet Genomics 2011 21 673 678 Selinski S Lehmann ML Blaszkewicz M Ovsiannikov D Moormann O Guballa C Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk Arch Toxicol 2012 86 1369 1378 Tang W Fu YP Figueroa JD Malats N Garcia-Closas M Chatterjee N Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer Hum Mol Genet 2012 21 1918 1930 Wu X Ye Y Kiemeney LA Sulem P Rafnar T Matullo G Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer Nat Genet 2009 41 991 995